Rating Change
Barclays analysts initiated coverage on DexCom, Inc. (NASDAQ:DXCM) with a rating of Overweight on October 07, 2026.
new coverageNASDAQ:DXCM
Barclays Initiates Coverage on DexCom, Inc. (DXCM) with Overweight
Barclays analysts initiated coverage on DexCom, Inc. (NASDAQ:DXCM) with a rating of Overweight on October 07, 2026.
At publication ·
What changed
DexCom, Inc. (NASDAQ:DXCM) · new coverage
- Firm
- Barclays
- Rating
- Overweight
- Price at event
- $84.30
- Market capitalization
- $27.0B
At a glance
Key takeaways
- Barclays initiated coverage of DexCom with an Overweight rating on October 7, 2026.
- DexCom stock trades at $84.30 with a $27.0B market cap and gained 23.7% over the past 52 weeks.
Market Context
DexCom, Inc. operates in the Healthcare sector. The stock currently trades at $84.30 with a market capitalization of $27.0B. The stock has gained 23.7% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DexCom, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for DexCom, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Oct 01, 2026 | RBC Capital | Outperform | N/A |
| Sep 18, 2026 | TD Cowen | Buy | N/A |
| Sep 18, 2026 | Truist Securities | Buy | N/A |
| Aug 04, 2026 | Argus Research | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View DXCM Stock Page
Frequently Asked Questions
What does the Overweight rating mean for DXCM?
A rating of Overweight from Barclays reflects the analyst's outlook on DexCom, Inc. (NASDAQ:DXCM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DXCM forecast page.